Cargando…
Can (immune and other) gene expression help us to treat depression?
It is becoming clearer that it might be a combination of different biological processes such as genetic, environmental, and psychological factors, together with immune system, stress response, brain neuroplasticity and the regulation of neurotransmitters, that leads to the development of major depre...
Autor principal: | Mariani, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611633/ https://www.ncbi.nlm.nih.gov/pubmed/34514441 http://dx.doi.org/10.1016/j.bbih.2021.100323 |
Ejemplares similares
-
Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
por: Nettis, Maria Antonietta
Publicado: (2021) -
Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression
por: Sforzini, Luca
Publicado: (2021) -
T regulatory cells as a potential therapeutic target in psychosis? Current challenges and future perspectives
por: Corsi-Zuelli, Fabiana, et al.
Publicado: (2021) -
Three's Company: Neuroimmune activation, sex, and memory at the tripartite synapse
por: Posillico, Caitlin K.
Publicado: (2021) -
Boosting stress resilience using flexibility as a framework to reduce depression risk
por: Madison, Annelise A.
Publicado: (2021)